Article
Recurrent Breast Cancer Cells Depend on <i>De novo</i> Pyrimidine Biosynthesis to Suppress Ferroptosis
2025-11-17
Abstract excerpt
Breast cancer recurrence remains a major clinical challenge, often associated with therapy resistance and altered metabolic states. To define metabolic vulnerabilities of recurrent disease, we performed a CRISPR knockout screen targeting 421 metabolic genes in paired primary and recurrent HER2-driven breast cancer cell lines. While both primary and recurrent tumors shared dependencies on core metabolic pathways, r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 271eaa0b-a55c-53d8-8036-60f8531cb940
- DOI
- 10.1101/2025.11.17.688927
